Defending the Indefensible
Executive Summary
One of the drug industry's favorite spectator sports these days seems to be pointing out that the much publicized pharmacy benefits manager (PBM) acquisitions of a couple of years ago have largely been failures. Even those who concede Medco Containment Services' success in increasing Merck & Co. Inc.'s market share argue that the PBM moves of three years ago were misguided.